Thomas McCourt
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Thomas McCourt
Thomas McCourt was last confirmed as Board Member at Pliant Therapeutics, Inc. (PLRX) in a filing dated April 23, 2025. Pliant Therapeutics, Inc. reported in an 8-K filed March 8, 2023 that Thomas McCourt was appointed director, effective March 6, 2023.
“On the Effective Date, the Board appointed, upon the recommendation of the Nominating and Corporate Governance Committee of the Board (the "Nominating and Governance Committee"), each of Thomas McCourt and Darren Cline to fill the Class II and Class I vacancies on the Board, respectively.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
2023-01-01–2025-04-23
Last confirmed by a filing; no departure on record
Company network
Recorded roles and call appearances connecting this person to public companies.
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.